Aerpio Therapeutics Announces Positive Data of TIME-2 trial of AKB-9778 in Diabetic Macular Edema
News, Type 2 Diabetes News
Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of vascular disorders with an emphasis on diseases of the eye, recently announced top-line ... Read more